Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Joseph P. Tkacz, Karen Rance, Douglas Waddell, Mark Aagren & Eva Hammerby. (2021) Real-world evidence costs of allergic rhinitis and allergy immunotherapy in the commercially insured United States population. Current Medical Research and Opinion 37:6, pages 957-965.
Read now
Read now
Zhiying Shen, Guolin Tan, Zhuqing Zhong, Siqing Ding & Fang Wang. (2019) Interactive Network Platform Improves Compliance and Efficacy of Subcutaneous Immunotherapy for Patients with Allergic Rhinitis. Patient Preference and Adherence 13, pages 2101-2110.
Read now
Read now
Articles from other publishers (4)
Magdalena Zemelka‐Wiacek, Ioana Agache, Cezmi A. Akdis, Mübeccel Akdis, Thomas B. Casale, Stephanie Dramburg, Karina Jahnz‐Różyk, Anna Kosowska, Paolo M. Matricardi, Oliver Pfaar, Mohamed H. Shamji & Marek Jutel. (2023) Hot topics in allergen immunotherapy, 2023: Current status and future perspective. Allergy.
Crossref
Crossref
Marcus S. Shaker, Giselle Mosnaim, John Oppenheimer, David Stukus, Elissa M. Abrams & Matthew Greenhawt. (2020) Health and Economic Outcomes of Home Maintenance Allergen Immunotherapy in Select Patients with High Health Literacy during the COVID-19 Pandemic: A Cost-Effectiveness Analysis During Exceptional Times. The Journal of Allergy and Clinical Immunology: In Practice 8:7, pages 2310-2321.e4.
Crossref
Crossref
Di Sun, Joseph Cafone, Marcus Shaker & Matthew Greenhawt. (2019) The cost-effectiveness of requiring universal vs contextual self-injectable epinephrine autoinjector for allergen immunotherapy. Annals of Allergy, Asthma & Immunology 123:6, pages 582-589.
Crossref
Crossref
Katherine R. Keefe, Minhtran Ngo-Howard, Michael P. Platt & Christopher D. Brook. (2018) Compliance With Subcutaneous Immunotherapy Appointments in an Urban Tertiary Care Setting. American Journal of Rhinology & Allergy 32:6, pages 473-477.
Crossref
Crossref